Welcome to Chrono, the future of personalized medicine.

At Chrono, we believe it's time to transform how medicine is delivered

Medication patches that deliver drug transdermally, through the skin, typically provide a steady dose of drug throughout the day, regardless of when the patient experiences symptoms. Our transdermal drug delivery platform is smarter: providing just the right amount of medication timed to when patients’ symptoms are at their strongest and medication is most needed. With our technology, drug delivery is personalized and has the potential to be significantly more efficacious.


And it's time to take a new approach to achieving outcomes

At Chrono, we know successful therapy for hard-to-treat conditions requires more than a one-size-fits-all approach. We are building a next generation transdermal drug delivery wearable that integrates biologically-timed drug delivery with personalized digital support to help people manage hard to treat conditions and achieve optimal clinical outcomes and lifestyle improvements.


Our Solution

Through the convergence of four technologies, we are uniquely positioned to achieve optimized clinical and patient lifestyle outcomes. 

Our platform represents a game-changing approach to medication therapy and behavior change and is poised to deliver on the full potential of personalized medicine. . 


Biologically-Timed Drug Delivery
Transdermal medication timed to the patient's needs

Compliance Measurements
Embedded sensors and digital reminders to help the patient stay on track and keep the care team in the loop

Behavioral Support
Personalized, proactive digital coaching and evidence-based learning

Data Analytics
Trends and insights at the patient and population level to tailor therapy and reveal insights





Phase 2

Smoking Cessation

Smoking is highly addictive and remains one of the world’s great killers: 6 million per year now and up to 1 billion by the turn of the century. There are 42 million smokers in the US. 70% want to quit, but current products work less than 10% of the time.

Our first product delivers a complete 10-week smoking cessation program. With nicotine replacement therapy timed to smokers’ peak cravings and coordinated digital support tools, we’re providing an integrated collection of clinically validated, personalized interventions to help smokers quit.  


Phase 1b



The United States is in the midst of a prescription opioid epidemic. There are now more than 2 million Americans addicted to prescription opioids and the number of unintentional overdose deaths has more than quadrupled since 1999. Effective solutions are needed, and the time is now. We are developing the world’s first FDA approved treatment to help patients become opioid free, for good.



Optimizing the timing and dosing of Parkinson’s Disease medications is absolutely essential to improving outcomes for patients. We are developing the world’s first solution that delivers the right amount of medication at the right times to minimize off time and dyskinesia, while simultaneously providing patient support and connectivity to caregivers and health care professionals.



Our drug delivery platform can automate the delivery of pain medication to ensure only the correct dosage is taken at the times when patients need it most, keeping pain at bay while minimizing potential addictions. Our solution will also accurately track real-time patient compliance and minimize diversion. Once the pain is gone, the platform can help individuals safely become pain medication free.


featured video

Alan Levy, Chairman and CEO of Chrono Therapeutics, discusses Chrono's innovative personalized drug delivery platform and why Chrono was named a 2016 Technology Pioneer by the World Economic Forum. 


Chrono in the News